During the last few decades the requirements for admission and registration of medicines have risen constantly. The aim of these directives is to guarantee the quality, safety and efficacy of medicines. PADMA Inc. gives top priority to making Tibetan medicinal products available to western patients within this regulatory framework.
PADMA pharmaceutical formulae are tested in line with the regulations for their safety and tolerability. Numerous experimental studies and clinical trials research effects and mechanisms of action as well as the efficacy of the products. Researchers are currently working with PADMA formulas in universities and clinics in Switzerland, Austria, Germany, Denmark, Israel and other countries.
Studies of PADMA products are available for the following conditions:
* Peripheral arterial occlusive disease (PAOD, intermittent claudication)
* Recurring respiratory tract infections
* Chronic Hepatitis B
* Juvenile chronic arthritis
* Digestive problems, constipation, flatulence, irritable bowel syndrome
Medical professionals can examine these studies here.